Fideuram Asset Management Ireland dac bought a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 6,826 shares of the financial services provider’s stock, valued at approximately $1,718,000.
Other institutional investors have also recently modified their holdings of the company. Asset Dedication LLC lifted its position in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares during the period. FNY Investment Advisers LLC bought a new stake in shares of CME Group during the 4th quarter valued at $27,000. Global Wealth Strategies & Associates lifted its position in shares of CME Group by 1,250.0% during the 4th quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 100 shares during the period. Legacy Wealth Managment LLC ID lifted its position in shares of CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 71 shares during the period. Finally, Anfield Capital Management LLC lifted its position in shares of CME Group by 197.4% during the 4th quarter. Anfield Capital Management LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after buying an additional 75 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft dropped their price objective on CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Keefe, Bruyette & Woods assumed coverage on CME Group in a research report on Wednesday, April 8th. They set a “market perform” rating and a $305.00 price objective for the company. Royal Bank Of Canada upped their price objective on CME Group from $295.00 to $302.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 5th. Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, April 26th. Finally, Morgan Stanley dropped their price objective on CME Group from $362.00 to $353.00 and set an “overweight” rating for the company in a research report on Thursday, April 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $305.29.
Trending Headlines about CME Group
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: CME announced that Chairman and CEO Terry Duffy will present at the Piper Sandler Global Exchange and Fintech Conference on June 4, which keeps the company visible to investors and may reinforce its growth story. Article Title
- Positive Sentiment: Recent coverage says CME’s planned 24/7 Bitcoin and Ethereum futures trading could attract more institutional crypto volume, which may support future derivatives activity and trading revenue. Article Title
- Neutral Sentiment: CME also lowered margin requirements on gold and silver futures, a move that may help keep trading active during volatile commodity markets but is not clearly a major fundamental catalyst. Article Title
- Neutral Sentiment: Macro commentary from the CME floor highlighted sticky inflation and stronger durable goods data, which could keep Fed policy uncertain and sustain trading activity, but the direct impact on CME stock is unclear. Article Title
- Negative Sentiment: Crypto articles suggesting Bitcoin’s “CME gap” may disappear with round-the-clock trading could reduce the market’s focus on CME-specific weekend price gaps, weakening one of the more visible trading narratives tied to the company’s crypto franchise. Article Title
CME Group Price Performance
CME Group stock opened at $273.54 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market capitalization of $99.12 billion, a PE ratio of 23.34, a P/E/G ratio of 3.10 and a beta of 0.23. CME Group Inc. has a 12 month low of $257.17 and a 12 month high of $329.16. The stock has a 50-day moving average price of $293.28 and a two-hundred day moving average price of $289.51.
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating the consensus estimate of $3.11 by $0.25. The firm had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The business’s quarterly revenue was up 14.5% on a year-over-year basis. During the same period last year, the company earned $2.80 earnings per share. Analysts expect that CME Group Inc. will post 12.28 EPS for the current year.
CME Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 1.9%. CME Group’s dividend payout ratio is presently 44.37%.
Insider Activity
In other news, General Counsel Jonathan L. Marcus sold 3,291 shares of the stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the sale, the general counsel owned 7,192 shares of the company’s stock, valued at approximately $2,397,597.04. This represents a 31.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction dated Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 44,044 shares of company stock valued at $13,297,507. Company insiders own 0.30% of the company’s stock.
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
- Dollar Tree Keeps Winning After Family Dollar Divorce
- Apple’s Agentic AI Plans Could Be Its Biggest Growth Story Yet
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
